Cite
HARVARD Citation
O'Hara, M. et al. (2021). CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. Lancet oncology. 22 (1), pp. 118-131. [Online].